Key Takeaways The gut-skin axis in dogs is a real, peer-reviewed phenomenon — but the published evidence supports adjunctive benefit for atopic dermatitis, not a cure for allergies. Three mechanisms have randomized controlled trial backing in dogs: omega-3 fatty acid supplementation, certain postbiotic preparations, and selected prebiotic fibers. “Probiotic fixes allergies” claims rely on extrapolation…

Key Takeaways Strain count is a marketing number, not a clinical outcome. The human and canine literature does not show that 15 or 20 strains outperform a well-chosen 2- or 3-strain formula. The “more is better” framing exploits a consumer heuristic borrowed from CFU counts and applies it where it has no validated meaning. Strain-stacking…

Key Takeaways The “more strains = better” claim is a marketing heuristic, not a clinical finding. No peer-reviewed canine study demonstrates that 15- or 20-strain products outperform well-designed 1- or 2-strain products. Strain identity matters more than strain count. A clinically documented Lactobacillus rhamnosus strain with proven efficacy outperforms an unidentified strain on a long…

Key Takeaways Key Takeaways Strain count on a dog probiotic label is a marketing metric, not an efficacy metric. The number of strains listed has no consistent correlation with clinical outcomes in the published canine literature. Multi-strain formulations introduce biological risks — competitive exclusion, antagonistic metabolite production, and unpredictable colonization — that are rarely disclosed…

Key Takeaways Strain count alone is a weak predictor of probiotic efficacy — the published canine evidence base for multi-strain superiority is thin and inconsistent. Strain identity, dose at point of consumption, and survival through the GI tract matter far more than how many strains appear on a label. The “more strains = better” narrative…

“`html This site has NO affiliate relationships with any supplement brand. We do not accept compensation for reviews, and no brand has editorial input into our reporting. Investigations are funded solely by site display advertising. — Editorial Notice Key Takeaways The “senior dog” supplement market is one of the fastest-growing segments in pet wellness, and…

Key Takeaways The label claim “30 Billion CFU” is a manufacturing-time figure. Actual viability at the point a consumer opens the package can be substantially lower. Soft chew matrices present specific, well-documented challenges to probiotic survival: moisture activity, heat during extrusion, and lipid oxidation. No publicly available third-party stability study for the Boops soft chew…